Miller, A A <br/><br/>
Fadrozole hydrochloride in postmenopausal patients with metastatic breast carcinoma.  [electronic resource] 

 -  Cancer  Aug 1996 
 - 789-93 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/(SICI)1097-0142(19960815)78:4<789::AID-CNCR15>3.0.CO;2-R  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents, Hormonal--adverse effects<br/>Aromatase Inhibitors<br/>Breast Neoplasms--blood<br/>Dose-Response Relationship, Drug<br/>Estrogen Antagonists--adverse effects<br/>Fadrozole--adverse effects<br/>Female<br/>Humans<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Neoplasms, Hormone-Dependent--blood<br/>Postmenopause<br/>Prospective Studies